Monash IVF Group Limited engages in the provision of assisted reproductive genetic and specialist women imaging services in Australia and Southeast Asia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. The company also provides tertiary level prenatal diagnostic, ultrasound, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is headquartered in Cremorne, Australia.
Frequently asked questions
What sector does MONASH IVF GROUP LTD (MIS) operate in?
MONASH IVF GROUP LTD belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is MONASH IVF GROUP LTD (MIS) current stock price?
As of the latest data, MONASH IVF GROUP LTD stock price is €0.43, with a previous close of €0.43.
What is MONASH IVF GROUP LTD (MIS) current market capitalization?
MONASH IVF GROUP LTD market cap is approximately 165.98 million.
What is MONASH IVF GROUP LTD (MIS) Earnings Per Share (EPS)?
The trailing EPS is €0.01.
What is MONASH IVF GROUP LTD (MIS) Price-to-Earnings (P/E) ratio?
MONASH IVF GROUP LTD current P/E ratio is 42.6.
Does MONASH IVF GROUP LTD (MIS) pay dividends?
Yes. MONASH IVF GROUP LTD pays semiannual dividends with an annualized yield of 2.41% and an estimated annual payout of €0.02 per share.
When is the next ex-dividend date for MONASH IVF GROUP LTD (MIS)?
The next ex-dividend date is scheduled for March 03, 2027.
What is MONASH IVF GROUP LTD (MIS) beta (volatility) score?
MONASH IVF GROUP LTD has a beta of 0.342, indicating lower volatility than the overall market.